EPO and secondary hyperparathyroidism: Additionally, although we made multivariable statistical adjustments, some unidentified clinical confounding factors may still influence EPO resistance, such as chronic inflammation, secondary hyperparathyroidism and pure red cell aplasia.[34] Finally, large differences can exist in genotypic distribution between ethnicities, and our study was conducted in an ethnically homogeneous Taiwanese population.